Sign in
Taking peopleNo phase

Levothyroxine for mild underactive thyroid in people having heart bypass surgery

Tests levothyroxine in people with subclinical hypothyroidism undergoing coronary artery bypass surgery.

Key facts

Who runs it
Seoul National University Bundang Hospital
Where
South Korea1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Thyroid Hormone Replacement After Coronary Artery Bypass Grafting for Patients With Subclinical Hypothyroidism
Status
Recruiting
People taking part
338 people, planned
Started
27 Feb 2022
Expected to end
26 Feb 2037
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • levothyroxine
Record updated
2 February 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with subclinical hypothyroidism who are scheduled for coronary artery bypass graft (CABG) heart surgery. Subclinical hypothyroidism means a mildly underactive thyroid.

Age
19 to 90 years
Sex
All sexes
Disease stage
Subclinical hypothyroidism: normal free T4 level and a TSH level greater than 4 μIU/mL, tested within 31 days before surgery. People must be scheduled for CABG surgery.
Earlier treatment
No LT4 (levothyroxine) in the previous 4 weeks. No antithyroid drugs (propylthiouracil, methimazole or carbimazole) in the previous 3 months.
Biomarker or test result
Normal free T4 and TSH greater than 4 μIU/mL, tested within 31 days before surgery.

Main reasons for not taking part

  • Repeat CABG surgery
  • Emergency CABG surgery
  • Use of LT4 within the previous 4 weeks
  • Use of antithyroid drugs within the previous 3 months
  • Severe other illness with life expectancy under 1 year, such as advanced cancer

The registry criteria, word for word

Show all 8 criteriaShow less

Who cannot take part

  • Patients who underwent repeat or emergency CABG surgery
  • Use of LT4 within the previous 4 weeks
  • Use of antithyroid drug use (propylthiouracil, methimazole, or carbimazole) within the previous 3 months
  • Severe comorbid conditions with a life expectancy of less than 1 year (e.g. advanced malignancy)

Other criteria

  • Eligibility Criteria
  • Adults aged 19 to 90 years
  • Patients scheduled to undergo coronary artery bypass graft (CABG) surgery
  • Subclinical hypothyroidism (SCH), defined as a normal free thyroxine (free T4) level and a thyroid-stimulating hormone (TSH) level greater than 4 μIU/mL, based on testing performed within 31 days prior to surgery

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 19 and 90 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to find out whether levothyroxine reduces complications and improves the prognosis of patients with subclinical hypothyroidism (SCH) undergoing coronary artery bypass grafting (CABG).

Read full original descriptionShow less

The main questions this study aims to answer are:

• Does levothyroxine reduce major adverse cardiovascular events (MACE), including cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, and new arrhythmias, in SCH patients undergoing CABG? Researchers will compare patients who take levothyroxine with those who do not.

Participants will:

* Be randomly assigned to either receive levothyroxine or not * Start the medication one day before surgery if assigned to the treatment group. * Have regular follow-up visits to check thyroid function and cardiovascular events for up to five years after surgery.

The 2 groups in the trial

  • LT4 groupTreatment being tested

    Participants in this group will receive levothyroxine

    Treatment: levothyroxine

  • Control groupNo study treatment, for comparison

    Participants in this group will not receive levothyroxine

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Thyroid Hormone Replacement After Coronary Artery Bypass Grafting for Patients With Subclinical Hypothyroidism
Plain-language title
Levothyroxine for mild underactive thyroid in people having heart bypass surgeryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT07380854, who can take part
Record updated
2 February 2026